Listed

Vericel Corp

VCELNasdaqCIK 887359HealthcareFiscal year ends Dec 31

Reports and events: 343 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Vericel Corp, Reports and events
FiledFormWhat it isAccession number
2019-08-0608:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-19-010032
2019-06-0317:11 ET8-K5.02 Departure or appointment of officers or directors0001104659-19-033468
2019-05-0717:04 ET10-QQuarterly reportPeriod 2019-03-310001628280-19-006102
2019-05-0708:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-19-005970
2019-05-0706:03 ET8-K1.01 Entry into a material agreement0001104659-19-027268
2019-05-0706:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-19-027253
2019-05-0116:01 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001104659-19-026009
2019-03-2016:07 ETDEF 14AProxy statementPeriod 2019-05-010001047469-19-001466
2019-02-2617:25 ET10-KAnnual reportPeriod 2018-12-310001628280-19-002007
2019-02-2608:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-19-001906
2018-12-2016:05 ET8-K1.02 Termination of a material agreement0001104659-18-074110
2018-11-0616:09 ET10-QQuarterly reportPeriod 2018-09-300001628280-18-013767
2018-11-0608:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-18-013687
2018-08-0616:55 ET10-QQuarterly reportPeriod 2018-06-300001628280-18-010558
2018-08-0616:21 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-18-010533
2018-07-3116:06 ET8-K1.01 Entry into a material agreement0001104659-18-048399
2018-06-0117:22 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001104659-18-037682
2018-05-3016:01 ET8-K1.02 Termination of a material agreement0001104659-18-036713
2018-05-0816:12 ET10-QQuarterly reportPeriod 2018-03-310001628280-18-006239
2018-05-0808:39 ET8-K2.02 Results of operations0001628280-18-006142
2018-05-0317:10 ET8-K5.07 Shareholder vote results0001104659-18-030322
2018-03-2217:04 ETDEF 14AProxy statementPeriod 2018-05-020001047469-18-002015
2018-03-0517:00 ET10-KAnnual reportPeriod 2017-12-310001628280-18-002753
2018-03-0508:45 ET8-K2.02 Results of operations0001628280-18-002718
2018-01-0808:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-18-001117
2017-12-2816:05 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001104659-17-075423
2017-12-0816:06 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-17-072521
2017-11-0709:11 ET10-QQuarterly reportPeriod 2017-09-300001628280-17-011022
2017-11-0707:50 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-17-011016
2017-09-1916:05 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-17-057884
2017-08-1016:20 ET8-K/A1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001104659-17-051067
2017-08-0914:07 ET10-QQuarterly reportPeriod 2017-06-300001628280-17-008431
2017-08-0913:22 ET8-K/A2.02 Results of operations0001628280-17-008426
2017-08-0908:21 ET8-K2.02 Results of operations0001628280-17-008400
2017-06-0216:09 ET8-K/A1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits0001104659-17-037229
2017-06-0216:08 ET8-K/A1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-17-037227
2017-06-0216:06 ET8-K/A1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001104659-17-037225
2017-05-1916:05 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement0001104659-17-034021
2017-05-1517:30 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-17-032855
2017-05-1016:45 ET10-QQuarterly reportPeriod 2017-03-310001628280-17-005367
2017-05-1008:10 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001628280-17-005301
2017-05-0516:44 ET8-K5.07 Shareholder vote results0001104659-17-030325
2017-03-2016:54 ETDEF 14AProxy statementPeriod 2017-05-030001047469-17-001792
2017-03-1308:31 ET10-KAnnual reportPeriod 2016-12-310001628280-17-002492
2017-03-1008:08 ET8-K2.02 Results of operations0001628280-17-002454
2017-03-0914:18 ET8-K3.02 Unregistered sale of equity0001104659-17-015426
2016-12-3016:08 ET8-K/A1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001104659-16-164564
2016-12-3016:05 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001104659-16-164553
2016-12-3016:03 ET8-K/A1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001104659-16-164538
2016-12-1617:28 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001104659-16-162645

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 12:33 ET. Listed shows no prices and gives no investment advice.